MIIC can make it easy for Minnesota Department of Human Services (DHS) licensed child cares to ensure the children in their care are up to date on immunizations and compliant with immunization laws.
Licensed child care centers (DHS Rule 3) can have direct access to MIIC to:
If you do not know if your organization currently participates in MIIC, contact the MIIC Help Desk at health.miichelp@state.mn.us with your DHS Rule 3 license number for assistance.
Family child cares (DHS Rule 2) can request access to MIIC immunization records for children in their care by submitting an immunization record request to Non-MIIC Provider Record Requests. Family child care providers can also send parents/guardians to Find My Immunization Record for options to access and share their child's MIIC immunization record.
Determining need for nirsevimab
Parents have multiple options to choose from to protect their newborn against severe disease from RSV for children born during the RSV season (October to March). Nirsevimab should be given in the first week of life for infants born shortly before and during season and whose birthing parent did not receive RSV vaccination during pregnancy.
To determine need for nirsevimab among children born during the RSV season, you will need to assess the RSV immunization history of both the newborn and the birthing parent.
-
Ask for documentation: Pregnant persons are encouraged to keep a record with them if they elected to receive the RSV vaccination between 32 to 36 weeks gestation.
-
Review records from hospital: Providers caring for persons during pregnancy are encouraged to include vaccination details in any medical records shared with the birthing hospital, as well as report RSV vaccination administration data to MIIC. Hospitals are also encouraged to include nirsevimab administration information in the newborn’s discharge summary and share with the newborn’s pediatrician.
-
Search in MIIC (with consent): The newborn’s provider must obtain consent from the birthing parent prior to viewing the birthing parent’s MIIC record. Most Minnesota providers exchange data with MIIC electronically, and many are unable to query MIIC for the birthing parent’s record if the birthing parent is not their patient. To avoid delays or missed opportunities to vaccinate, birthing hospitals are encouraged to include the birthing parent’s RSV vaccination history in the newborn’s discharge summary when possible.
Nirsevimab should be given shortly before the start of the RSV season for infants less than 8 months of age and entering their first RSV season (October through March). Children ages 8 to 19 months who are at increased risk of severe RSV disease or are American Indian or Alaska Native should also receive nirsevimab shortly before the start of the RSV season.
To determine need for nirsevimab among children entering their first or second RSV season, you will need to assess the child’s RSV immunization history.
-
Search in MIIC: Review a client’s immunization history in MIIC to assess previous nirsevimab dose(s) received during the current season.
Reporting nirsevimab administration data to MIIC
All providers, including birthing hospitals, who administer nirsevimab are strongly encouraged to report the administration data to MIIC. Birthing hospitals may be administering nirsevimab before the baby has been named. MIIC will not accept immunizations reported under a newborn’s “placeholder name” or “baby alias” (e.g., Baby Boy Mohamed, Twin 1 Smith). Birthing hospitals are encouraged to work with their technical and/or EHR support teams to identify workflows that allow for nirsevimab administration data to be sent to MIIC after the baby’s legal name has been assigned. Because this could result in a potential delay in reporting the data to MIIC, birthing hospitals are also encouraged to document nirsevimab decisions in the newborn’s discharge summary and provide the parent/guardian a record of nirsevimab administration.
Again, all providers who administer nirsevimab are strongly encouraged to report the administration data to MIIC within 7 days of birth or as soon as possible after the baby’s legal name is identified. Outpatient providers may receive record of a newborn’s receipt of nirsevimab (for example, through hospital discharge summary or a record the parent/guardian received from the administering provider) without that dose on the newborn’s MIIC record. In these situations, the outpatient provider is encouraged to report the nirsevimab administration data as ‘historical’ to MIIC. Learn more at Capturing Immunizations Not Currently in MIIC (PDF).
Additional nirsevimab questions?
Learn more about Immunization options to protect infants and toddlers at Respiratory Syncytial Virus (RSV) for Health Professionals.
For additional questions about reporting nirsevimab administration data to MIIC, or about accessing MIIC to view the newborn’s or the birthing parent’s RSV immunization history, contact the MIIC Help Desk at health.miichelp@state.mn.us.
In MIIC, “pending” clients refer to temporary client records that require further review before combining with an existing record or creating a new record. These pending records are created when clients submitted through data exchange have more than one potential match in MIIC. Multiple matches can occur for a variety of reasons:
- Twins typically have very similar names and the exact same birth date and other demographic information. An incoming message that matches exactly to one twin can still be an almost exact match to the other twin, so it requires further review to know which twin’s record the new immunization should be added to.
- Outside of multiple births, other people may coincidentally have the same or a very similar name and birth date combination. Incoming messages for one of these people will still appear to be a potential match for the other person, particularly if the rest of their demographic information (i.e., mother’s maiden name, address, phone) is incomplete or inconsistent across the records.
- One person can also have multiple records in MIIC. These fragmented records are usually the result of data exchange difficulties, data entry errors, or immunization information submitted under incomplete or different demographic information (i.e., new addresses, name changes). In these cases, multiple existing records need to be combined with the pending record, rather than just determining which one record to add the pending information to.
The MIIC team regularly reviews and determines if these pending clients should be merged with one or more existing MIIC records or they should be added as a new record. Most pending clients are resolved within a few business days, although higher volume times like flu season and back to school vaccination can extend this response time. It is also important to remember that the best way to prevent an unnecessary pending client and to ensure all information is properly added to the appropriate record is to always gather and send complete and up-to-date demographic information whenever you see your patients. Provider organizations are encouraged to update demographic information in MIIC, even if identified outside of a vaccination encounter. Doing so could help prevent a pending client-related delay in adding new immunization information to the client’s record.
Several updates were made to MIIC the evening of Sept. 25. You may notice some changes including:
MIIC assessment reports: Updated statewide averages and descriptive text
The standard Childhood, Adolescent, Adult, and Single Vaccine (Flu) Assessment Reports have been updated with the 2024 Minnesota averages.
The descriptive text in the Childhood Summary Assessment Report has been updated to clarify that children’s up to date with rotavirus status is assessed as of 8 months of age. All other vaccines in this report assess whether a child is up to date as of 24 months of age. This is not a change in how rotavirus status is assessed, but a change in the footnote and descriptive text of the table to provide further clarification.
MIIC’s dose column is no longer used
The “dose” column was removed from the manage immunizations screen in MIIC. MIIC will continue to record the dose information sent to us by organizations and to return it when queried via data exchange.
|
|
Before |
|
|
After |
|